Homocysteine plasma levels are independently associated with insulin resistance in normal weight, overweight and obese pre-menopausal women

被引:0
作者
De Pergola, G
Pannacciulli, N
Zamboni, M
Minenna, A
Brocco, G
Sciaraffia, M
Bosello, O
Giorgino, R
机构
[1] Univ Bari, Dept Emergency & Transplant, Sect Internal Med Endocrinol & Metab Dis, Bari, Italy
[2] Univ Verona, Div Geriatr, I-37100 Verona, Italy
[3] Verona Univ Hosp, Lab Chem & Clin Microscopy, Verona, Italy
关键词
homocysteine; insulin resistance; cardiovascular risk;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives: The aim of the present study was to examine the relationship of homocysteine (Hey) plasma levels to insulin resistance (IR). Design: A cross-sectional study in a primary care setting. Subjects and Methods: Fasting Hey levels were measured in the plasma of 44 pre-menopausal women [17 normal weight (body mass index BMI 20.0-24.9 kg/m(2)), 7 overweight (BMI 25.0-29.9 kg/m(2)), 20 obese (BMI greater than or equal to 30.0 kg/m(2))], aged 18-45 yr. Other measurements included: central fat accumulation, as evaluated by waist circumference; IR, as calculated by homeostatic model assessment (HOMA(IR)); systolic and diastolic blood pressure; and fasting concentrations of glucose, insulin and lipids (total cholesterol, HDL-cholesterol, triglycerides). Results: Hey was positively correlated with insulin concentrations (p <0.01), HOMA(IR) (p <0.01), and systolic and diastolic blood pressure (p <0.01 and p <0.05, respectively). After multivariate analysis, only HOMAIR maintained an independent association with Hey (p <0.05), irrespective of age and other anthropometric and biochemical variables. Lastly, we observed a gradual increase in Hey plasma levels across the age- and BMI-matched quartiles in which the whole population was divided according to HOMA(IR) levels (F: 2.73,p <0.05 for linear trend). Conclusions: Our study shows that Hey plasma levels are independently associated with IR in apparently healthy normal weight, overweight and obese pre-menopausal women, thus suggesting a possible role of IR and/or hyperinsulinaemia in increasing Hcy plasma levels. Since Hcy is a well-known cardiovascular risk factor, higher Hey plasma levels may well be a further mechanism explaining the higher risk of coronary heart disease in patients affected by IR. (C) 2001, Editrice Kurtis.
引用
收藏
页码:253 / 258
页数:6
相关论文
共 30 条
[1]   Plasma homocysteine concentrations in healthy volunteers are not related to differences in insulin-mediated glucose disposal [J].
Abbasi, F ;
Facchini, F ;
Humphreys, MH ;
Reaven, GR .
ATHEROSCLEROSIS, 1999, 146 (01) :175-178
[2]   Plasma total homocysteine levels in subjects with hyperinsulinemia [J].
Bar-On, H ;
Kidron, M ;
Friedlander, Y ;
Ben-Yehuda, A ;
Selhub, J ;
Rosenberg, IH ;
Friedman, G .
JOURNAL OF INTERNAL MEDICINE, 2000, 247 (02) :287-294
[3]   SKELETAL-MUSCLE BLOOD-FLOW - A POSSIBLE LINK BETWEEN INSULIN RESISTANCE AND BLOOD-PRESSURE [J].
BARON, AD ;
BRECHTELHOOK, G ;
JOHNSON, A ;
HARDIN, D .
HYPERTENSION, 1993, 21 (02) :129-135
[4]   LIPID-PEROXIDATION AND SUSCEPTIBILITY OF LOW-DENSITY-LIPOPROTEIN TO IN-VITRO OXIDATION IN HYPERHOMOCYSTEINAEMIA [J].
BLOM, HJ ;
KLEINVELD, HA ;
BOERS, GHJ ;
DEMACKER, PNM ;
HAKLEMMERS, HLM ;
POELEPOTHOFF, MTWBT ;
TRIJBELS, JMF .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1995, 25 (03) :149-154
[5]   A QUANTITATIVE ASSESSMENT OF PLASMA HOMOCYSTEINE AS A RISK FACTOR FOR VASCULAR-DISEASE - PROBABLE BENEFITS OF INCREASING FOLIC-ACID INTAKES [J].
BOUSHEY, CJ ;
BERESFORD, SAA ;
OMENN, GS ;
MOTULSKY, AG .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (13) :1049-1057
[6]   Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus:: a new link between diabetic nephropathy and cardiovascular disease? [J].
Chico, A ;
Pérez, A ;
Córdoba, A ;
Arcelús, R ;
Carreras, G ;
de Leiva, A ;
González-Sastre, F ;
Blanco-Vaca, F .
DIABETOLOGIA, 1998, 41 (06) :684-693
[7]   Hyperinsulinemia as an independent risk factor for ischemic heart disease [J].
Despres, JP ;
Lamarche, B ;
Mauriege, P ;
Cantin, B ;
Dagenais, GR ;
Moorjani, S ;
Lupien, PJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (15) :952-957
[8]  
Drzewoski J, 2000, DIABETES NUTR METAB, V13, P319
[9]  
Gavin JR, 1997, DIABETES CARE, V20, P1183
[10]  
Giltay EJ, 1998, ATHEROSCLEROSIS, V139, P197